Balyasny Asset Management
ELDN icon

Balyasny Asset Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Balyasny Asset Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-61,520
Closed -$209K – 2129
2025
Q1 		$209K Buy
61,520
+28,897
+89% +$98K ﹤0.01% 1806
2024
Q4 		$134K Buy
+32,623
New +$134K ﹤0.01% 1791